Literature DB >> 12759250

Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation.

Sunfa Cheng1, David H Lovett.   

Abstract

Progressive renal interstitial fibrosis and tubular atrophy represent the final injury pathway for all commonly encountered forms of renal disease that lead to end-stage renal failure. It has been recently recognized that myofibroblastic cells are the major contributors to the deposition of interstitial collagens. While there are several potential cellular sources of myofibroblasts, attention has focused on the transformation of the organized tubular epithelium to the myofibroblastic phenotype, a process potently driven both in vitro and in vivo by transforming growth factor-beta1 (TGF-beta1). Integrity of the underlying basal lamina provides cellular signals that maintain the epithelial phenotype, and disruption by discrete proteases could potentially initiate the transformation process. We demonstrate that TGF-beta1 coordinately stimulates the synthesis of a specific matrix metalloproteinase, gelatinase A (MMP-2), and its activator protease, MT1-MMP (MMP-14), and that active gelatinase A is absolutely required for epithelial-mesenchymal transformation induced by TGF-beta1. In addition, purified active gelatinase A alone is sufficient to induce epithelial-mesenchymal transformation in the absence of exogenous TGF-beta1. Gelatinase A may also mediate epithelial-mesenchymal transformation in a paracrine manner through the proteolytic generation of active TGF-beta1 peptide. MT1-MMP and gelatinase A were co-localized to sites of active epithelial-mesenchymal transformation and basal lamina disruption in the rat remnant kidney model of progressive renal fibrosis. These studies indicate that a discrete matrix metalloproteinase, gelatinase A, is capable of inducing the complex genetic rearrangements that characterize renal tubular epithelial-mesenchymal transformation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759250      PMCID: PMC1868144          DOI: 10.1016/S0002-9440(10)64327-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  80 in total

1.  Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP).

Authors:  H Sato; T Takino; T Kinoshita; K Imai; Y Okada; W G Stetler Stevenson; M Seiki
Journal:  FEBS Lett       Date:  1996-05-06       Impact factor: 4.124

Review 2.  Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis.

Authors:  A M Gressner
Journal:  Kidney Int Suppl       Date:  1996-05       Impact factor: 10.545

3.  Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity.

Authors:  D Pei; S J Weiss
Journal:  J Biol Chem       Date:  1996-04-12       Impact factor: 5.157

4.  Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.

Authors:  K Imai; E Ohuchi; T Aoki; H Nomura; Y Fujii; H Sato; M Seiki; Y Okada
Journal:  Cancer Res       Date:  1996-06-15       Impact factor: 12.701

5.  Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation.

Authors:  J Turck; A S Pollock; L K Lee; H P Marti; D H Lovett
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

6.  Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.

Authors:  J B Kopp; V M Factor; M Mozes; P Nagy; N Sanderson; E P Böttinger; P E Klotman; S S Thorgeirsson
Journal:  Lab Invest       Date:  1996-06       Impact factor: 5.662

7.  Interstitial myofibroblasts in experimental renal infection and scarring.

Authors:  T D Hewitson; H L Wu; G J Becker
Journal:  Am J Nephrol       Date:  1995       Impact factor: 3.754

8.  Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney.

Authors:  Y Isaka; D K Brees; K Ikegaya; Y Kaneda; E Imai; N A Noble; W A Border
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

9.  Myofibroblasts and the progression of experimental glomerulonephritis.

Authors:  G Zhang; P J Moorhead; A M el Nahas
Journal:  Exp Nephrol       Date:  1995 Sep-Oct

10.  Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy.

Authors:  J I McMillan; J W Riordan; W G Couser; A S Pollock; D H Lovett
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

View more
  87 in total

Review 1.  Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases.

Authors:  Paola Nisticò; Mina J Bissell; Derek C Radisky
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

2.  Epithelial-mesenchymal transition to be or not to be? Is the answer yes and no at the same time?

Authors:  Cheng Zhu; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2010-04-04       Impact factor: 2.370

3.  S100A4 participates in epithelial-mesenchymal transition in breast cancer via targeting MMP2.

Authors:  Han Xu; Mengquan Li; Yue Zhou; Feng Wang; Xiangke Li; Liuxing Wang; Qingxia Fan
Journal:  Tumour Biol       Date:  2015-09-26

Review 4.  Epithelial-mesenchymal transition: An emerging target in tissue fibrosis.

Authors:  Meirong Li; Fuxin Luan; Yali Zhao; Haojie Hao; Yong Zhou; Weidong Han; Xiaobing Fu
Journal:  Exp Biol Med (Maywood)       Date:  2015-09-11

5.  An in vitro model for the pro-fibrotic effects of retinoids: mechanisms of action.

Authors:  A C Rankin; B M Hendry; J P Corcoran; Q Xu
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

6.  Blockade of ERK1/2 by U0126 alleviates uric acid-induced EMT and tubular cell injury in rats with hyperuricemic nephropathy.

Authors:  Min Tao; Yingfeng Shi; Lunxian Tang; Yi Wang; Lu Fang; Wei Jiang; Tao Lin; Andong Qiu; Shougang Zhuang; Na Liu
Journal:  Am J Physiol Renal Physiol       Date:  2019-01-16

7.  Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin.

Authors:  András Masszi; Lingzhi Fan; László Rosivall; Christopher A McCulloch; Ori D Rotstein; István Mucsi; András Kapus
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis.

Authors:  Benjamin D Humphreys; Shuei-Liong Lin; Akio Kobayashi; Thomas E Hudson; Brian T Nowlin; Joseph V Bonventre; M Todd Valerius; Andrew P McMahon; Jeremy S Duffield
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

Review 9.  New insights into epithelial-mesenchymal transition in kidney fibrosis.

Authors:  Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

10.  Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis.

Authors:  Jacek Rysz; Maciej Banach; Robert A Stolarek; Dimitri P Mikhailidis; Aleksandra Cialkowska-Rysz; Lech Pokoca; Mariusz Piechota; Zbigniew Baj
Journal:  Int Urol Nephrol       Date:  2009-12-02       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.